Selective response: The fully synthetic vaccine shown, which contains a glycopeptide antigen from the tumor-associated mucin MUC1 and an immunostimulating T-cell epitope from ovalbumin, induces a highly specific immune response in mice. The induced antibody reacts with the glycopeptides and analogues that carry additional tumor-associated TN antigen monosaccharides in their sequence.
No takes yet. Share an insight, caveat, or question.
Westerlind et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: